These results, together with the KDM5C-associated methylation profile of “stem cell differentiation” genes—observed in the larger and independent TCGA sample cohorts (Figure 4C)—corroborate the finding that GBM tumors are enriched in stem cell markers compared to the healthy tissue. Here, KDM5C is linked to glioblastoma.